All shareholders through index funds and ETFs. Google State Street. The first line of the results says ETFs. These companies are not buying because they analyzed Anavex and decided to buy. These companies have to buy (or sell) Anavex and other biotechs to include at the proper weighting in the funds. This idea is not debatable or controversial except for those who can't handle the truth. This has been explained many times across may boards and WGT crowd either doesn't understand how these firms work or doesn't want to know the truth.